Enhancement of the CD8+ T cell response to a subdominant epitope of respiratory syncytial virus by deletion of an immunodominant epitope

Vaccine

Volumn 26, Issue 37, 2008, Pages 4775-4782

  Mok, Hoyin ^a   Lee, Sujin ^a   Wright, David W ^a,c   Crowe Jr , James E ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

DNA vaccines; Epitopes; Respiratory syncytial viruses; T lymphocyte

Indexed keywords

DNA VACCINE; EPITOPE; PLASMID DNA; PROTEIN M2;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INFECTION PREVENTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS;

AMINO ACID SUBSTITUTION; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; FEMALE; IMMUNODOMINANT EPITOPES; MICE; MICE, INBRED BALB C; PLASMIDS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUSES; VACCINES, DNA; VIRAL PROTEINS;

EID: 49549119961     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.07.012     Document Type: Article

References (36)

1. Falsey A.R., Hennessey P.A., Formica M.A., Cox C., and Walsh E.E. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 352 17 (2005) 1749-1759
2. Holzel A., Parker L., Patterson W.H., White L.L., Thompson K.M., and Tobin J.O. The isolation of respiratory syncytial virus from children with acute respiratory disease. Lancet 1 (1963) 295-298
3. Chanock R., and Finberg L. Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). II. Epidemiologic aspects of infection in infants and young children. Am J Hyg 66 3 (1957) 291-300
4. Graham B.S. Pathogenesis of respiratory syncytial virus vaccine-augmented pathology. Am J Respir Crit Care Med 152 4 Pt 2 (1995) S63-S66
5. Murphy B.R., and Walsh E.E. Formalin-inactivated respiratory syncytial virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-inhibiting activity. J Clin Microbiol 26 8 (1988) 1595-1597
6. Murphy B.R., Prince G.A., Walsh E.E., Kim H.W., Parrott R.H., Hemming V.G., et al. Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine. J Clin Microbiol 24 2 (1986) 197-202
7. Graham B.S., Bunton L.A., Wright P.F., and Karzon D.T. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest 88 3 (1991) 1026-1033
8. Cherrie A.H., Anderson K., Wertz G.W., and Openshaw P.J. Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22 K, and 1b proteins of respiratory syncytial virus. J Virol 66 4 (1992) 2102-2110
9. Rock M.T., and Crowe Jr. J.E. Identification of a novel human leucocyte antigen-A*01-restricted cytotoxic T-lymphocyte epitope in the respiratory syncytial virus fusion protein. Immunology 108 4 (2003) 474-480
10. Venter M., Rock M., Puren A.J., Tiemessen C.T., and Crowe Jr. J.E. Respiratory syncytial virus nucleoprotein-specific cytotoxic T-cell epitopes in a South African population of diverse HLA types are conserved in circulating field strains. J Virol 77 13 (2003) 7319-7329
11. Bangham C.R., Openshaw P.J., Ball L.A., King A.M., Wertz G.W., and Askonas B.A. Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants. J Immunol 137 12 (1986) 3973-3977
12. Chang J., Srikiatkhachorn A., and Braciale T.J. Visualization and characterization of respiratory syncytial virus F-specific CD8(+) T cells during experimental virus infection. J Immunol 167 8 (2001) 4254-4260
13. Jiang S., Borthwick N.J., Morrison P., Gao G.F., and Steward M.W. Virus-specific CTL responses induced by an H-2K(d)-restricted, motif-negative 15-mer peptide from the fusion protein of respiratory syncytial virus. J Gen Virol 83 Pt 2 (2002) 429-438
14. Openshaw P.J., Anderson K., Wertz G.W., and Askonas B.A. The 22,000-kilodalton protein of respiratory syncytial virus is a major target for Kd-restricted cytotoxic T lymphocytes from mice primed by infection. J Virol 64 4 (1990) 1683-1689
15. Rutigliano J.A., Rock M.T., Johnson A.K., Crowe Jr. J.E., and Graham B.S. Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus. Virology 337 2 (2005) 335-343
16. Rutigliano J.A., Ruckwardt T.J., Martin J.E., and Graham B.S. Relative dominance of epitope-specific CD8+ T cell responses in an F1 hybrid mouse model of respiratory syncytial virus infection. Virology 362 2 (2007) 314-319
17. Terrosi C., Di Genova G., Savellini G.G., Correale P., Blardi P., and Cusi M.G. Immunological characterization of respiratory syncytial virus N protein epitopes recognized by human cytotoxic T lymphocytes. Viral Immunol 20 3 (2007) 399-406
18. Brehm M.A., Pinto A.K., Daniels K.A., Schneck J.P., Welsh R.M., and Selin L.K. T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens. Nat Immunol 3 7 (2002) 627-634
19. Busch D.H., and Pamer E.G. MHC class I/peptide stability: implications for immunodominance, in vitro proliferation, and diversity of responding CTL. J Immunol 160 9 (1998) 4441-4448
20. Probst H.C., Tschannen K., Gallimore A., Martinic M., Basler M., Dumrese T., et al. Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression. J Immunol 171 10 (2003) 5415-5422
21. van der Most R.G., Murali-Krishna K., Lanier J.G., Wherry E.J., Puglielli M.T., Blattman J.N., et al. Changing immunodominance patterns in antiviral CD8 T-cell responses after loss of epitope presentation or chronic antigenic stimulation. Virology 315 1 (2003) 93-102
22. Yewdell J.W., and Bennink J.R. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu Rev Immunol 17 (1999) 51-88
23. Rodriguez F., Harkins S., Slifka M.K., and Whitton J.L. Immunodominance in virus-induced CD8(+) T-cell responses is dramatically modified by DNA immunization and is regulated by gamma interferon. J Virol 76 9 (2002) 4251-4259
24. Frahm N., Kiepiela P., Adams S., Linde C.H., Hewitt H.S., Sango K., et al. Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes. Nat Immunol 7 2 (2006) 173-178
25. Friedrich T.C., Valentine L.E., Yant L.J., Rakasz E.G., Piaskowski S.M., Furlott J.R., et al. Subdominant CD8+ T-cell responses are involved in durable control of AIDS virus replication. J Virol 81 7 (2007) 3465-3476
26. Subbramanian R.A., Kuroda M.J., Charini W.A., Barouch D.H., Costantino C., Santra S., et al. Magnitude and diversity of cytotoxic-T-lymphocyte responses elicited by multiepitope DNA vaccination in rhesus monkeys. J Virol 77 18 (2003) 10113-10118
27. Lee S., Miller S.A., Wright D.W., Rock M.T., and Crowe Jr. J.E. Tissue-specific regulation of CD8+ T-lymphocyte immunodominance in respiratory syncytial virus infection. J Virol 81 5 (2007) 2349-2358
28. Murali-Krishna K., Altman J.D., Suresh M., Sourdive D., Zajac A., and Ahmed R. In vivo dynamics of anti-viral CD8 T cell responses to different epitopes. An evaluation of bystander activation in primary and secondary responses to viral infection. Adv Exp Med Biol 452 (1998) 123-142
29. Fu T.M., Friedman A., Ulmer J.B., Liu M.A., and Donnelly J.J. Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization. J Virol 71 4 (1997) 2715-2721
30. Barouch D.H., Craiu A., Santra S., Egan M.A., Schmitz J.E., Kuroda M.J., et al. Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys. J Virol 75 5 (2001) 2462-2467
31. Loirat D., Lemonnier F.A., and Michel M.L. Multiepitopic HLA-A*0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization. J Immunol 165 8 (2000) 4748-4755
32. Bergmann C.C., Altman J.D., Hinton D., and Stohlman S.A. Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the central nervous system. J Immunol 163 6 (1999) 3379-3387
33. Allan J.E., and Doherty P.C. Consequences of a single Ir-gene defect for the pathogenesis of lymphocytic choriomeningitis. Immunogenetics 21 6 (1985) 581-589
34. Rodriguez F., Slifka M.K., Harkins S., and Whitton J.L. Two overlapping subdominant epitopes identified by DNA immunization induce protective CD8(+) T-cell populations with differing cytolytic activities. J Virol 75 16 (2001) 7399-7409
35. Vallbracht S., Jessen B., Mrusek S., Enders A., Collins P.L., Ehl S., et al. Influence of a single viral epitope on T cell response and disease after infection of mice with respiratory syncytial virus. J Immunol 179 12 (2007) 8264-8273
36. Kulkarni A.B., Morse III H.C., Bennink J.R., Yewdell J.W., and Murphy B.R. Immunization of mice with vaccinia virus-M2 recombinant induces epitope-specific and cross-reactive Kd-restricted CD8+ cytotoxic T cells. J Virol 67 7 (1993) 4086-4092